Latest filing published 05 Oct 2023 for Celularity Inc.
Insider track record
No signal scores available.
Sorrento Therapeutics, Inc.: trading record in brief
Sorrento Therapeutics, Inc. has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Celularity Inc and Scilex Holding Co. Over a trading history stretching from 19 January 2023 to 5 October 2023, the count stands at 4 filings.
Every open-market trade on record is a sale: 3 sales. No amount is published for 3 filings, which the totals therefore leave out.
The latest filing, published on 5 October 2023, reports an open-market sale in Celularity Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Sorrento Therapeutics, Inc.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 6,307,158 sharesClass A Common StockSEC:0001104659-23-107259:1
- 9,064,539 sharesClass A Common StockSEC:0001104659-23-107259:0
- 60,068,585 sharesCommon StockSEC:0001104659-23-103527:0
- 73,740,795 shares0Common StockSEC:0000899243-23-002368:0
4 of 4 declarations
